Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 93

Sort by

Sort Order Select

Journal Articles

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (Ixa Dara dex) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; Results of the Interim Efficacy Analysis of the Phase II HOVON 143 Study

Blood (2019) 134 (Supplement_1): 695.

https://doi.org/10.1182/blood-2019-121694

Published: 2019

Journal Articles

Efficacy and Safety of Nivolumab Combined with Daratumumab with or without Low-Dose Cyclophosphamide in Relapsed/Refractory Multiple Myeloma; Interim Analysis of the Phase 2 Nivo-Dara Study

Christie P.M. Verkleij, MD, Monique C. Minnema, Okke de Weerdt, MD, Patricia W.C. Bosman, MSc, Kristine A. Frerichs, MD, Alexandra J. Croockewit, MD PhD, Saskia K. Klein, MD PhD, Gerard Bos, MD PhD, Tuna Mutis, Wouter J. Plattel, MD, Ellen van der Spek, MD PhD, Annemiek Broyl, MD PhD, Pieter Sonneveld, Sonja Zweegman, MD PhD, Mark-David Levin, MD PhD, Niels W. C. J. Van De Donk, MD PhD

Blood (2019) 134 (Supplement_1): 1879.

https://doi.org/10.1182/blood-2019-124339

Published: 2019

Journal Articles

Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study

Shan Chen, MD, Ke Zhao, MD, Ren Lin, MD, Shunqing Wang, Zhiping Fan, MD, Fen Huang, MD, Xiaoyong Chen, PhD, Danian Nie, MD, Xin Du, MD, Ziwen Guo, MD, Dongjun Lin, MD, Li Xuan, MD, Na Xu, MD, Jing Sun, MD, Andy Peng Xiang, PhD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 871.

https://doi.org/10.1182/blood-2019-124455

Published: 2019

Journal Articles

Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis

Brock Hodges, Jodi-Anne T Stewart, BS, Mark Rodeghier, PhD, Karina L Wilkerson, NP, MSN, Adetola A. Kassim, MDMS, Michael R. DeBaun, MDMPH

Blood (2019) 134 (Supplement_1): 1012.

https://doi.org/10.1182/blood-2019-123428

Published: 2019

Journal Articles

Evaluation of Pulmonary Function in Patient with Transfusion Dependent Beta Thalassemia with Severe Iron Overload

Mohamed A Yassin, MBBS, MSc, Mushtaq Ahmad, MD, Shehab Mohamed, MD, Khadra S Yassin, BSC, Abdulqadir Jeprel Nashwan, BSN, MSN, Vincenzo Desanctis, MD PhD, Ashraf Tawfiq Soliman, MD PhD

Blood (2019) 134 (Supplement_1): 4818.

https://doi.org/10.1182/blood-2019-121828

Published: 2019

Journal Articles

Effect of Cyclosporine Inhalation Solution (CIS) on Lung Function and Inflammatory Biomarkers in Patients with Hematopoietic Stem Cell Transplant (HSCT) Associated Bronchiolitis Obliterans Syndrome (BOS)

Janhavi Athale, MD, Nicole J Gormley, MD, Robert Reger, MS, Sara Alsaaty, MS, Debra Reda, BSN, Tatyana Worthy, MSN, Ankit Saxena, Ph. D, Xin Tian, Ph. D, Richard W. Childs, MD, Anthony F Suffredini, MD

Blood (2019) 134 (Supplement_1): 4552.

https://doi.org/10.1182/blood-2019-122966

Published: 2019

Journal Articles

Ibrutinib for Chronic Pulmonary Graft-Versus-Host-Disease after Progression on Prior Therapy

Surbhi Singhal, MD, Theresa Brondstetter, RN, David B. Miklos, MD PhD, Debra Kate Tierney, RN, PhD, Joe Hsu, MD, Laveena Chhatwani, MD

Blood (2019) 134 (Supplement_1): 4532.

https://doi.org/10.1182/blood-2019-129171

Published: 2019

Journal Articles

Toxicities of Brentuximab Vedotin in Children and Adolescents with Hodgkin Lymphoma

Ruetima Titapiwatanakun, MD, Sukhjeet Singh Batth, MD, Katherine Baker, NP, Wendy Tcheng, MD, Karen S. Fernandez, MD

Blood (2019) 134 (Supplement_1): 5298.

https://doi.org/10.1182/blood-2019-122973

Published: 2019

Journal Articles

Prevalence of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in the USA, Europe and Japan

Emilie Hofstetter, MBA, Noreen Roth Henig, MD, Dominik Kappeler, MD

Blood (2019) 134 (Supplement_1): 5678.

https://doi.org/10.1182/blood-2019-128226

Published: 2019

Journal Articles

Lung Function Impairment in Pediatric Subjects with Sickle Cell Anemia from Nigeria Is Associatede with Associated Low Steady Haemoglobin

Baba PD Inusa, MD, Livingstone Gayus Dogara, MBBS, FMCPath, Ramatu Zubair, MBBS, MPH, Chiara Zuiani, MD, Christoper Audu, Ashel Dache Sunday, MSC Nutrition, Muhammed Zakari Sani, MD, Luigi Castriotta, MD, Michele Arigliani, MD

Blood (2018) 132 (Supplement 1): 3659.

https://doi.org/10.1182/blood-2018-99-116328

Published: 2018

Journal Articles

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Adam Rock, MD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Rasha Raslan, MD, Michel Gowhari, DO, Shivi Jain, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3664.

https://doi.org/10.1182/blood-2018-99-114820

Published: 2018

Journal Articles

Ruxolitinib and Steroid Refractory/Dependent Bronchiolitis Obliterans after Hematopoietic Cell Transplantation: A Steroid Sparing Agent That Also Resulted in Improved Lung Function in Children

Michelle Schoettler, MD, Meera Subramaniam, MD, Steven P. Margossian, MD PhD

Blood (2018) 132 (Supplement 1): 3407.

https://doi.org/10.1182/blood-2018-99-114971

Published: 2018

Journal Articles

Pilot Results from an Integrated Pediatric Pulmonary Clinic on Outcomes in Children with Sickle Cell Disease

Vandy Black, MDMSc, Dima Ezmigna, MBBS, Laurie Duckworth, PhD ARNP

Blood (2018) 132 (Supplement 1): 4694.

https://doi.org/10.1182/blood-2018-99-117496

Published: 2018

Journal Articles

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Parastoo B. Dahi, MD, Chikaodi Obioha, Sheila Kenny, NP, Patrick Hilden, MS, Molly Maloy, MS, Alexander Geyer, MD, Wendy Schaffer, MD, Roni Tamari, MD, Craig S. Sauter, MD, Ann A. Jakubowski, MD PhD, Sergio Giralt, MD

Blood (2018) 132 (Supplement 1): 4620.

https://doi.org/10.1182/blood-2018-99-112632

Published: 2018

Journal Articles

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Paul Lin, MD PhD, Lauren Westfall Veltri, MD, Katy Rezvani, MD PhD, Betul Oran, MD MS, Sairah Ahmed, MD, Gheath Alatrash, DO, PhD, Rohtesh S. Mehta, MD MPH, MS, Gabriela Rondon, MD, Partow Kebriaei, MD, Uday Popat, MD, Yago Nieto, MD PhD, Chitra Hosing, MD, Roy B Jones, MD PhD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, Elizabeth J. Shpall, MD, Richard E Champlin, MD, David Marin, MD

Blood (2018) 132 (Supplement 1): 4667.

https://doi.org/10.1182/blood-2018-99-112749

Published: 2018

Journal Articles

Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study

Vaishali Sanchorawala, MD, Shayna Sarosiek, MD, John Mark Sloan, MD, Dina Brauneis, NP, Mary Ellen Migre, Meredith Mistark, Stephanie Santos, Ramon Cruz, Salli Fennessey, Anthony C Shelton, RN

Blood (2018) 132 (Supplement 1): 2005.

https://doi.org/10.1182/blood-2018-99-112991

Published: 2018

Journal Articles

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study

Claudia A.M. Stege, MD, Kazem Nasserinejad, PhD, Mark-David Levin, MDPhD, Noortje Thielen, MD PhD, Saskia K. Klein, MD PhD, Inge Ludwig, MD MSc, Matthijs Westerman, MD, Paula F Ypma, MDPhD, Yavuz Bilgin, MDPhD, Maaike Sohne, MD, Esther de Waal, PhD, Niels WCJ van de Donk, MD PhD, Pieter Sonneveld, MDPhD, Sonja Zweegman, MDPhD

Blood (2018) 132 (Supplement 1): 596.

https://doi.org/10.1182/blood-2018-99-114668

Published: 2018

Journal Articles

Methacholine Challenge Test Reveals a High Prevalence of Subclinical Severe Airway Hyper-Reactivity in Children and Yound Adults with Sickle Cell Disease Which Correlates with Higher Sickle Acute Events and Acute Chest

Marthe-Sandrine Eiymo Mwa Mpollo, PhD, Sharat Chandra, MBBS,MD, Michael R. DeBaun, MD MPH, Uwe Christians, MD PhD, William Hardie, MD, Karen Kalinyak, MD, Punam Malik, MD

Blood (2017) 130 (Supplement 1): 761.

https://doi.org/10.1182/blood.V130.Suppl_1.761.761

Published: 2017

Journal Articles

Safety and Tolerability of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Preliminary Results of a Phase II Study

Vaishali Sanchorawala, MD, Shayna Sarosiek, MD, John Mark Sloan, MD, Dina Brauneis, NP, Mary Ellen Migre, Meredith Mistark, Stephanie Santos, Salli Fennessey, Anthony C Shelton, RN

Blood (2017) 130 (Supplement 1): 507.

https://doi.org/10.1182/blood.V130.Suppl_1.507.507

Published: 2017

Journal Articles

Pre-Transplant Pulmonary Function Test Parameters of FEF50% (Forced expiratory flow at 50% of forced vital capacity) and RV (residual volume) in Combination Can Predict the Risk for Development of Lung Gvhd after Allogeneic Transplantation

Wilson Lam, MD, Arjun Datt Law, MBBS, MD DM, Fotios V. Michelis, MD PhD, Santhosh Thyagu, MD, Auro Viswabandya, MDMDcine,DM Clinical Hematology, Jeffrey H. Lipton, MD PhD, Hans A. Messner, MD PhD, Theodore Marras, MD MSc, Shikha Mittoo, MD MHS, Dennis Kim, MD

Blood (2017) 130 (Supplement 1): 1973.

https://doi.org/10.1182/blood.V130.Suppl_1.1973.1973

Published: 2017

NARROW

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (Ixa Dara dex) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; Results of the Interim Efficacy Analysis of the Phase II HOVON 143 Study

Efficacy and Safety of Nivolumab Combined with Daratumumab with or without Low-Dose Cyclophosphamide in Relapsed/Refractory Multiple Myeloma; Interim Analysis of the Phase 2 Nivo-Dara Study

Efficacy of Mesenchymal Stem Cells in Bronchiolitis Obliterans Syndrome after Allogeneic HSCT: A Multicenter Prospective Cohort Study

Decline in Forced Expiratory Volume in 1 Second in Older Adults with Sickle Cell Disease Is Similar to Adults with Cystic Fibrosis

Evaluation of Pulmonary Function in Patient with Transfusion Dependent Beta Thalassemia with Severe Iron Overload

Effect of Cyclosporine Inhalation Solution (CIS) on Lung Function and Inflammatory Biomarkers in Patients with Hematopoietic Stem Cell Transplant (HSCT) Associated Bronchiolitis Obliterans Syndrome (BOS)

Ibrutinib for Chronic Pulmonary Graft-Versus-Host-Disease after Progression on Prior Therapy

Toxicities of Brentuximab Vedotin in Children and Adolescents with Hodgkin Lymphoma

Prevalence of Bronchiolitis Obliterans Syndrome (BOS) Following Allogeneic Hematopoietic Stem Cell Transplant (alloHSCT) in the USA, Europe and Japan

Lung Function Impairment in Pediatric Subjects with Sickle Cell Anemia from Nigeria Is Associatede with Associated Low Steady Haemoglobin

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Ruxolitinib and Steroid Refractory/Dependent Bronchiolitis Obliterans after Hematopoietic Cell Transplantation: A Steroid Sparing Agent That Also Resulted in Improved Lung Function in Children

Pilot Results from an Integrated Pediatric Pulmonary Clinic on Outcomes in Children with Sickle Cell Disease

Late Effects of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation (HDT-AHCT) in Elderly Patients with Lymphoma

Allotransplants for Patients 65 Years or Older with High-Risk Acute Myeloid Leukemia

Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study

Methacholine Challenge Test Reveals a High Prevalence of Subclinical Severe Airway Hyper-Reactivity in Children and Yound Adults with Sickle Cell Disease Which Correlates with Higher Sickle Acute Events and Acute Chest

Safety and Tolerability of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Preliminary Results of a Phase II Study

Pre-Transplant Pulmonary Function Test Parameters of FEF50% (Forced expiratory flow at 50% of forced vital capacity) and RV (residual volume) in Combination Can Predict the Risk for Development of Lung Gvhd after Allogeneic Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only